Positive tests for respiratory illnesses have been steadily climbing for weeks in British Columbia, especially for flu and ...

Influenza A, COVID-19 and norovirus (stomach flu) are on the rise, according to the Centers for Disease Control and ...

GSK and Pfizer's respiratory syncytial virus (RSV) vaccines will carry warnings that they can increase the risk of developing ...

For most people RSV is like a cold, but for infants and older people it can lead to serious infections. Here's what to know.

For immunocompromised individuals, antibody response to respiratory syncytial virus (RSV) vaccines is heterogeneous an ...

Vaccines and monoclonal antibodies are reducing RSV hospitalizations, but high costs and limited access in low-income ...

Flu and COVID-19 case counts are high and rising in most parts of the United States, according to recent data by the Centers ...

Respiratory syncytial virus is the leading cause of hospitalization among U.S. infants. A vaccine, nirsevimab, can reduce the ...

With COVID vaccine sales in the doldrums and a respiratory syncytial virus (RSV) vaccine market in “contraction”, Moderna CEO ...

Common RSV symptoms include coughing, congestion, and headaches, as well as trouble eating, drinking, and swallowing. RSV ...